A Katz P Zalewski
10.1038/sj.bjc.6601478
Br J Cancer
2003 Dec;89 Suppl 2(Suppl 2):S15-8.
CC BY
https://pubmed.ncbi.nlm.nih.gov/14661048/
Antineoplastic Agents / therapeutic use Brain Neoplasms / drug therapy Carcinoma, Non-Small-Cell Lung / drug therapy Lung Neoplasms / drug therapy Neoplasm Recurrence, Local / drug therapy Quinazolines / therapeutic use
Antineoplastic Agents / therapeutic use Brain Neoplasms / drug therapy Carcinoma, Non-Small-Cell Lung / drug therapy Lung Neoplasms / drug therapy Neoplasm Recurrence, Local / drug therapy Quinazolines / therapeutic use Review Brain Neoplasms / secondary Carcinoma, Non-Small-Cell Lung / secondary Gefitinib Humans Lung Neoplasms / pathology Quality of Life Antineoplastic Agents Quinazolines Gefitinib
PMC2750244
14661048
Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib
2003